| Call 2014/2015 subtopics:

3.2 Regenerative medicine and biomaterials

Regenerative medicine remains one of the great challenges of clinical practice. Many of the world’s leading pathological processes, including cardiovascular diseases, cancer, diabetes, and traumatic injuries, could be alleviated by regenerative medicine. For example, new methods for pancreatic endocrine cells regeneration can be used to treat diabetes, tissue engineering therapy can help in coronary artery disease, and novel nervous tissue regeneration technologies can be utilized in stroke treatment. Effective biomaterials for tissue regeneration will, therefore, find applications in practically every clinical discipline. Regenerative medicine has the potential to improve patient outcomes, lower the incidence of complications, and reduce hospital stays. Such technologies will enable cost‐effective treatments, and lessen morbidity and mortality.

Documents

Contact

  • Dr Andreas Kahle

    • Senior Scientific Officer
      DLR Project Management Agency
      European and International Cooperation
    • Heinrich-Konen-Str. 1
    • D-53227 Bonn Germany
    • Telephone: +49 228 3821 1829
    • Fax: +49 228 3821 1400
    • Email Address: Andreas.Kahle@dlr.de
  • Nina Schüle

    • Senior Administrative Officer
      DLR Project Management Agency
      European and International Cooperation
    • Heinrich-Konen-Str. 1
    • 53227 Bonn | Germany
    • Telephone: +49 228 3821 1889
    • Fax: +49 228 3821 1444
    • Email Address: Nina.Schuele@dlr.de